1. Medtech Insight
  2. >>Device Area
  3. >>Diabetic Care

Dexcom Announces CGM Real-Time Data Now Available On Garmin Wearables, Bike Computers

 
• By Marion Webb

Dexcom is making CGM data available through consumer devices starting with Garmin’s smartwatches and bicycle computers.

Garmin watch with Dexcom G6

After receiving the nod from the US Food and Drug Administration in July to let third-party developers integrate real-time continuous glucose monitoring data into their devices, DexCom, Inc. announced its first partnership is with Garmin, a leader in GPS navigation and wearable technology for the fitness and outdoor markets.

Dexcom G6 users can now download glucose levels and trends on a Garmin smartwatch or cycling computer with Dexcom apps available from the Connect IQ Store, Dexcom said. (Also see...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Diabetic Care

Abbott’s FreeStyle Libre CGM Reduces Cardiovascular Disease-Related Hospitalization

 
• By Natasha Barrow

The REFLECT studies showed a 78% reduction in cardiovascular disease-related hospitalization for people living with type 1 diabetes with prior low blood sugar episodes.

Roche To Localize CGM Manufacturing in US with $550M Indiana Site Investment

 
• By Shubham Singh

Roche’s Indianapolis site currently produces 5.2 billion Accu-Chek test strips annually and supports distribution to 53 countries. The new CGM line will add to an already diversified operational footprint, which includes R&D, laboratories, manufacturing, and IT services.

Consumer Healthtech Investment Totaled $4.5BN In 2024, But Bar Is High Amid Economic Uncertainty

 
• By Marion Webb

Global investment in consumer healthtech increased by 9% year-over-year in 2024, totaling $4.5bn, with significant interest in mental health solutions, according to Galen Growth. While the first quarter of 2025 saw raised confidence and investments, the Trump administration’s new tariffs and sweeping changes to healthcare have introduced new uncertainties.

Dexcom Puts Stelo On Amazon, Setting Up Consumer Showdown With Abbott

 
• By Shubham Singh

In addition to broader distribution, Dexcom is investing heavily in software enhancements for Stelo. The 180-day data lookback feature is just one of several planned upgrades intended to improve personalization and user engagement.

More from Device Area